GL1X · GenesisL1 explorer

Research workbench

Ligand binding to farnesoid-X-receptor

Analyse Ligand binding to farnesoid-X-receptor in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
5Q0O
Type
protein
Length
485 residues
Chains
4
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Bile acid receptor; Coactivator peptide src-1 HD3
UniProt
Q96RI1, A8K1V4
Ligands
9L7, CL
Pockets
5 · best druggability 0.85

Structure

x-ray diffraction · 4 distinct chains · 72% helix, 0% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ABile acid receptorprotein23072% helix, 0% strandQ96RI1
BCoactivator peptide src-1 HD3protein1267% helix, 0% strandA8K1V4
CBile acid receptorprotein23271% helix, 0% strandQ96RI1
DCoactivator peptide src-1 HD3protein1173% helix, 0% strandA8K1V4

Ligands and binding sites

  • 9L7 · (2S)-2-{2-[4-(benzenecarbonyl)phenyl]-1H-benzimidazol-1-yl}-N,2-dicyclohexylacetamide · ligand · 2 copies · chains A, C
  • CL · Chloride ion · ion · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

5 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
13370.850.94389L7
24580.840.90559L7
3650.400.8015empty
4800.340.7514empty
5660.320.7514empty

Interfaces

3 interfaces between chains.

  • A–B · 617 Ų buried · 6 hydrogen bonds · protein-protein
  • C–D · 579 Ų buried · 11 hydrogen bonds · protein-protein
  • A–C · 348 Ų buried · 3 hydrogen bonds · protein-protein

Compared structures

  • 5Q0O · Ligand binding to FARNESOID-X-RECEPTOR · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.